Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6
Open Access
- 22 December 2006
- journal article
- other
- Published by Wolters Kluwer Health in Hepatology
- Vol. 45 (1) , 258-259
- https://doi.org/10.1002/hep.21505
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapyHepatology, 2006
- Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaJournal of Hepatology, 2005
- International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis CPublished by Elsevier ,2005